Kenvue, the American company that makes Tylenol, says the US Food and Drug Administration should not make proposed changes to ...
Kenvue urged the Food and Drug Administration to deny a proposal to add further warnings to acetaminophen products after the ...
Kenvue has urged U.S. regulators to reject a request seeking autism warning label on its popular over-the-counter pain ...
While news feeds and social media are abuzz with unproven claims about links between acetaminophen and autism in children, ...
Barchart on MSN
Tylenol-Maker Kenvue’s Stock Is Down 30% in 2025. Its Fate May Be in the FDA’s Hands.
Kenvue (KVUE) could really use some good news. The Johnson & Johnson (JNJ) spinoff faced longlasting troubles regarding its ...
Barchart on MSN
This Billionaire Investor Is ‘Thrilled’ to Own Kenvue Stock Despite Tylenol Turbulence. Should You Buy KVUE Here?
Kenvue stock is down 28% in 2025 amid controversy surrounding its Tylenol brand, which is linked to autism when used during ...
Last month, Trump warned of a link between autism and acetaminophen use in pregnancy, going against advice from medical ...
Kenvue, the maker of Tylenol, defended the safety of the pain reliever as federal health officials prepare to update acetaminophen warning labels following claims that the drug may increase the risk ...
That slump has driven its dividend yield up to more than 5%. While Kenvue stock is down this year, it could soar in 2026.
The Senate Finance Committee hearing with Robert F. Kennedy Jr. was explosive. The Secretary of Health and Human Services was accused of “reckless ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback